Table 4.
Variables | ST307 (n = 6) | Other ST (n = 5) | p Value |
---|---|---|---|
Sex | >0.99 | ||
Female n (%) | 2 (33) | 2 (40) | |
Male n (%) | 4 (67) | 3 (60) | |
Age, years, median (IQR) | 66 (63, 75) | 63 (56, 66) | 0.64 |
Risk factors | |||
Hospitalized ≥2 d in the prior 90 d | 5 (83) | 3 (60) | |
Antibiotic treatment in the prior 90 d | 4 (67) | 2(40) | |
Wound care at home | 2 (33) | 1 (20) | |
Outpatient chemotherapy | 2 (33) | — | |
History of immunosuppressive therapy | 2 (33) | — | |
Hemodialysis in the prior 90 d | — | — | |
At least 1 risk factor | 6 (100) | 3 (60) | 0.18 |
No known risk factors | — | 2 (40) | 0.06 |
ESBL carrier | 6 (100) | 2 (40) | 0.06 |
Abbreviations: d: days; ESBL: extended-spectrum β-lactamase, ST: sequence typing.